Inferra AI / Company / AXON
Axon Enterprise
AXON · Industrials
Last earnings Aug 5, 2026 · Next earnings Nov 5, 2026
Key results
Revenuequarter
$604 million
revenue of $604 million, up 31% year over year Software Services revenue grows 39% to $263 million Annual recurring revenue grows 34% to $1.1 billion
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Software Services revenuequarter
31%
revenue of $604 million, up 31% year over year Software Services revenue grows 39% to $263 million Annual recurring revenue grows 34% to $1.1 billion
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Net incomequarter
$88 million
Net income of $88 million supports non-GAAP
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
First quarter revenue reached $604 million, representing 31% year-over-year growth and marking our 13th consecutive quarter of growth exceeding 25%.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
We continued to demonstrate profitable expansion, with a net income margin of 14.6% and an Adjusted EBITDA margin of 25.7%.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Growthquarter
up 39%
Our performance was led by Software Services, which generated $263 million in revenue, up 39% year over year, driven by robust demand for our premium software offerings and an expanding user base.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Recurring revenuequarter
34%
Customers continue to find increasing value in our growing suite of solutions, with Annual Recurring Revenue (ARR) increasing 34% year over year to $1.1 billion and net revenue retention of 123%.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Connected Devices revenuequarter
$341 million
Connected Devices revenue totaled $341 million, up 26% year over year, with growth across all major device categories.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
TASER revenuequarter
19%
TASER revenue grew 19% year over year to $195 million, reflecting continued strength in demand for TASER 10.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
AI analysis
Q1 2025 · reported May 7, 2025
Based on: Earnings release + parent 8-K — transcript not held
The quarter in charts
Guidance ladder — revenue
Delivered vs the company's guided range
EX-99 · May 7, 2025 Guide as stated by the company; range and midpoint computed from the stated figure.
Headline figures
| Metric | Q1 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Revenue | $604 million | — | — |
| Software Services revenue | 31% | — | — |
| Net income | $88 million | — | — |
| Growth | up 39% | — | — |
| Recurring revenue | 34% | — | — |
| Connected Devices revenue | $341 million | — | — |
| TASER revenue | 19% | — | — |
Guidance · company-stated
Direction: Raised
“com Axon reports Q1 2025 revenue of $604 million, up 31% year over year Software Services revenue grows 39% to $263 million Annual recurring revenue grows 34% to $1.1 billion Net income of $88 million supports non-GAAP net income of $115 million and Adjusted EBITDA of $155 million Raises full year revenue outlook to a range of $2.60 billion to $2.70 billion, up from $2.55 billion to $2.65 billion.”
“We continue to target an Adjusted EBITDA margin of approximately 25%, or $650 million to $675 million, an increase from our previous outlook of $640 million to $670 million.”
“This is an increase from our prior revenue guidance range of $2.55 billion to $2.65 billion.”
“This is an increase from our prior Adjusted EBITDA margin guidance range of $640 million to $670 million.”
“Strong alignment with our customers, expanding vertical applications and sustained product innovation underpin Axon s increased outlook for the remainder of the year.”
“Our Adjusted EBITDA guidance includes expected impacts from recently introduced reciprocal tariffs.”
Classified from the release's primary full-year outlook statement.
Capital allocation
agent accounting of certain reseller arrangements under ASC 606 previously reported in our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, as well as the restatement related to the balance sheet presentation of our convertible notes due 2027 discussed in Item 4.02 of the Form 8-K filed on May 7, 2025.
What changed vs last quarter
- Guide midpoint vs latest-quarter revenue 0.0% computed from stated figures
Event summary
Axon Enterprise Q1 2025 — revenue of $604 million, up 31% year over year Software Services revenue grows 39% to $263 million Annual recurring revenue grows 34% to $1.1 billion
Based on: Earnings release + parent 8-K — transcript not held
Guidance & outlook
Direction: Raised
Revenue: “com Axon reports Q1 2025 revenue of $604 million, up 31% year over year Software Services revenue grows 39% to $263 million Annual recurring revenue grows 34% to $1.1 billion Net income of $88 million supports non-GAAP net income of $115 million and Adjusted EBITDA of $155 million Raises full year revenue outlook to a range of $2.60 billion to $2.70 billion, up from $2.55 billion to $2.65 billion.”
Margin: “We continue to target an Adjusted EBITDA margin of approximately 25%, or $650 million to $675 million, an increase from our previous outlook of $640 million to $670 million.”
Revenue: “This is an increase from our prior revenue guidance range of $2.55 billion to $2.65 billion.”
Margin: “This is an increase from our prior Adjusted EBITDA margin guidance range of $640 million to $670 million.”
Revenue — Raised (“Raises”)
“com Axon reports Q1 2025 revenue of $604 million, up 31% year over year Software Services revenue grows 39% to $263 million Annual recurring revenue grows 34% to $1.1 billion Net income of $88 million supports non-GAAP net income of $115 million and Adjusted EBITDA of $155 million Raises full year revenue outlook to a range of $2.60 billion to $2.70 billion, up from $2.55 billion to $2.65 billion.”
Company outlook — Raised (“increased”)
“Strong alignment with our customers, expanding vertical applications and sustained product innovation underpin Axon s increased outlook for the remainder of the year.”
Margin — Raised (“increase”)
“We continue to target an Adjusted EBITDA margin of approximately 25%, or $650 million to $675 million, an increase from our previous outlook of $640 million to $670 million.”
Revenue — Raised (“increase”)
“This is an increase from our prior revenue guidance range of $2.55 billion to $2.65 billion.”
Company outlook — Initiated (“introduced”)
“Our Adjusted EBITDA guidance includes expected impacts from recently introduced reciprocal tariffs.”
Margin — Raised (“increase”)
“This is an increase from our prior Adjusted EBITDA margin guidance range of $640 million to $670 million.”
Classified from the release's primary full-year outlook statement.
Capital allocation
agent accounting of certain reseller arrangements under ASC 606 previously reported in our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, as well as the restatement related to the balance sheet presentation of our convertible notes due 2027 discussed in Item 4.02 of the Form 8-K filed on May 7, 2025.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
We expect 2025 CapEx to be in the range of $160 million to $180 million.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Our 2025 CapEx plans include long-term R D investment projects, continued capacity expansion, global facility build-outs and new product development costs.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Expected capital expenditures do not include costs related to investments in a new headquarters as we await local zoning and planning decisions that could impact our development plans.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Strategy & priorities
We continued to demonstrate profitable expansion, with a net income margin of 14.6% and an Adjusted EBITDA margin of 25.7%.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
We provide Adjusted EBITDA guidance, rather than net income guidance, due to the inherent difficulty of forecasting certain types of expenses and gains such as stock-based compensation, income tax expenses and gains or losses on marketable securities and strategic investments, which affect net income but not Adjusted EBITDA.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Our 2025 CapEx plans include long-term R D investment projects, continued capacity expansion, global facility build-outs and new product development costs.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Risks & headwinds
Across nearly 90 breakout sessions and daily keynotes, we highlighted innovations designed to meet the evolving challenges faced by public safety professionals.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
2025 Outlook The following forward-looking statements reflect Axon s expectations as of May 7, 2025 and are subject to risks and uncertainties.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Our Adjusted EBITDA guidance includes expected impacts from recently introduced reciprocal tariffs.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Achievement of future results is subject to risks, uncertainties and potentially inaccurate assumptions.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.
SEC original ↗Axon Enterprise — Earnings release (8-K exhibit)EX-99May 7, 2025
Competitors
Competitors & peers
Named in the company’s own filings
Filings
64 documents- Q2 2026
- 8-KAXON
Sep 21, 2026
- 8-KAXON
Sep 15, 2026
- 10-QAXON
Aug 6, 2026
- 8-KAXON
Aug 5, 2026
- 8-KAXON
Jul 10, 2026
- Q1 2026
- 8-KAXON
Jun 1, 2026
- 10-QAXON
May 7, 2026
- 8-KAXON
May 6, 2026
- 8-KAXON
Apr 10, 2026
- Q4 2025
- 8-KAXON
Mar 11, 2026
- 10-KAXON
Feb 25, 2026
- 8-KAXON
Feb 24, 2026
- 8-KAXON
Feb 13, 2026
- 8-K/AAXON
Feb 4, 2026
- Q3 2025
- 8-KAXON
Dec 18, 2025
- 8-K/AAXON
Dec 17, 2025
- 8-KAXON
Dec 10, 2025
- 10-QAXON
Nov 5, 2025
- 8-KAXON
Nov 4, 2025
- Q2 2025
- 8-KAXON
Sep 2, 2025
- 10-QAXON
Aug 5, 2025
- 8-KAXON
Aug 4, 2025
- Q1 2025
- 8-KAXON
Jun 2, 2025
- 10-QAXON
May 7, 2025
- 8-KAXON
May 7, 2025
- Q4 2024
- 8-K/AAXON
Mar 14, 2025
- 8-KAXON
Mar 11, 2025
- EX-99AXON
Mar 11, 2025
- 8-KAXON
Mar 7, 2025
- EX-99AXON
Mar 7, 2025
- 8-KAXON
Mar 5, 2025
- EX-99AXON
Mar 5, 2025
- 10-KAXON
Feb 28, 2025
- 8-KAXON
Feb 25, 2025
- Q3 2024
- 10-QAXON
Nov 8, 2024
- 8-KAXON
Nov 7, 2024
- Q2 2024
- 10-QAXON
Aug 7, 2024
- 8-KAXON
Aug 6, 2024
- Q1 2024
- 8-KAXON
May 13, 2024
- 8-KAXON
May 13, 2024
- 10-QAXON
May 7, 2024
- 8-KAXON
May 6, 2024
- Q4 2023
- 8-KAXON
Mar 5, 2024
- 8-KAXON
Feb 27, 2024
- 10-KAXON
Feb 27, 2024
- Q3 2023
- 8-KAXON
Dec 21, 2023
- 8-KAXON
Dec 14, 2023
- 8-KAXON
Nov 7, 2023
- 10-QAXON
Nov 7, 2023
- Q2 2023
- 8-K/AAXON
Sep 8, 2023
- 8-K/AAXON
Aug 30, 2023
- 8-KAXON
Aug 8, 2023
- 10-QAXON
Aug 8, 2023
- 8-KAXON
Jul 5, 2023
- Q1 2023
- 8-KAXON
Jun 2, 2023
- 8-KAXON
May 9, 2023
- 10-QAXON
May 9, 2023
- Q4 2022
- 8-KAXON
Mar 15, 2023
- EX-99AXON
Mar 15, 2023
- 8-KAXON
Feb 28, 2023
- 10-KAXON
Feb 28, 2023
- Q3 2022
- 8-KAXON
Dec 19, 2022
- 8-KAXON
Dec 14, 2022
- 8-KAXON
Dec 9, 2022
Earnings releases
17 documents- Q2 2026
- EX-99AXON
Sep 21, 2026
- EX-99AXON
Sep 15, 2026
- EX-99AXON
- Q1 2026
- EX-99AXON
- Q4 2025
- EX-99AXON
Feb 24, 2026
- Q3 2025
- EX-99AXON
- Q2 2025
- EX-99AXON
- Q1 2025
- EX-99AXON
- Q4 2024
- EX-99AXON
Feb 25, 2025
- Q3 2024
- EX-99AXON
- Q2 2024
- EX-99AXON
- Q1 2024
- EX-99AXON
- Q4 2023
- EX-99AXON
Feb 27, 2024
- Q3 2023
- EX-99AXON
- Q2 2023
- EX-99AXON
- Q1 2023
- EX-99AXON
- Q4 2022
- EX-99AXON
Feb 28, 2023
Presentations
0 documentsNo presentations for Axon Enterprise are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Axon Enterprise are held in this edition of the library.
Mentioned by
1 companyOther tracked companies whose held documents mention Axon Enterprise by name or ticker. A mention is counted once per document, from the document text the library holds.
“ and margin guidance. Outperformance was driven primarily by the continued performance of AXON 2.0, our AI-based advertising… …transaction bonuses, publisher bonuses, MoPub acquisition transition services, restructuring costs, impairment and loss in ”
See also the earnings calendar for every tracked company’s next earnings date.